Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Hosted on MSN20h
Celltrion booth at inflammatory bowel disease research gatheringCelltrion booth at inflammatory bowel disease research gathering Visitors attend a presentation by South Korean ...
A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...
Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...
It basically kept getting passed off as, like, anxiety or stress since I was meeting someone new and eating new foods...” ...
Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...
Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Larry Sears and Sally Zlotnick Sears recently donated $1 million to the Crohn’s and Colitis Foundation, according to a news release.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results